Alec Ingold

Fullback

Age: 28
Free Agency: 2027 (Void)
Accrued Seasons: 5
  • 2024 Salary Cap Charge: $3,130,000 (1.22% of cap)
  • 2024 Cash Payout: $3,540,000 (1.65% of spending)
  • 2024 Cash to Cap Ratio: 1.13
  • Contract Value: $12,200,000 ($4,066,667 APY)
  • Fully Guaranteed Money: $6,080,000
  • Contract Ranking: 2/16 at FB

Current Contract

(Extension, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202327$1,080,000$1,500,000$0$0$1,080,000$2,580,0001.1%
202428$1,125,000$1,165,000$340,000$500,000$0$3,130,0001.2%
202529$3,350,000$1,165,000$340,000$0$0$4,855,0001.9%
202630$3,550,000$1,165,000$340,000$0$0$5,055,0001.8%
202731Void$415,000VoidVoidVoid$830,0000.3%
202832Void$415,000VoidVoidVoid$0--
Total$9,105,000$5,825,000$1,020,000$500,000$1,080,000$16,450,000

Contract Notes

Alec Ingold signed a three year contract extension with the Dolphins worth $12.2 million. Ingold received a $3 million signing bonus and his 2023 base salary is fully guaranteed. $2 million of his 2024 salary is guaranteed for injury. There are annual per game bonuses of $340,000. The extension created $1.17 million in 2023 cap room.

Cash Flows

- fully earned money
- unearned or partially earned money
$4.1M
$8.1M
$12.2M
2023202420252026
Cash Due$1,080,000$3,540,000$3,690,000$3,890,000
Running Cash$1,080,000$4,620,000$8,310,000$12,200,000
Career Earnings: $9,610,000
Career APY: $1,922,000
Potential Earnings: $20,730,000
Total Guarantees: $9,590,000
Largest Cash Payment: $4,080,000 (2023)
Largest Cap Number: $5,055,000 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RaidersUDFAExpired20193$1,765,000$588,333$10,000$2,030,000115.0%$676,667
DolphinsSFAExtended20222$6,500,000$3,250,000$3,500,000$3,500,00053.8%$3,500,000
DolphinsExtensionActive20233$12,200,000$4,066,667$6,080,000$4,080,00033.4%$4,080,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Raiders3$2,030,000$676,667$2,030,0000.0%$00.0%
Dolphins2$7,580,000$3,790,000$5,330,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Raiders$495,000$3,333$0$0$0$498,3330.3%$505,000
2020Raiders$675,000$3,333$0$0$0$678,3330.3%$675,000
2021Raiders$850,000$3,334$0$0$0$853,3340.4%$850,000
2022Dolphins$2,000,000$750,000$0$0$2,000,000$2,750,0001.3%$3,500,000
2023Dolphins$1,080,000$1,500,000$0$0$1,080,000$2,580,0001.1%$4,080,000
2024Dolphins$1,125,000$1,165,000$340,000$500,000$0$3,130,0001.2%$3,540,000
2025Dolphins$3,350,000$1,165,000$340,000$0$0$4,855,0001.9%$3,690,000
2026Dolphins$3,550,000$1,165,000$340,000$0$0$5,055,0001.8%$3,890,000
2027Dolphins$0$415,000$0$0$0$830,0000.3%$0
2028Dolphins$0$415,000$0$0$0$0--$0
Total$13,125,000$6,585,000$1,020,000$500,000$3,080,000$21,230,000$20,730,000

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2019160020.2%46.7%10171.706447.3100
2020160021.3%49.6%341.30121109.2100
202190011.9%30.4%210.5010858.5100
2022170039.5%29.6%681.31151057.0100
2023170037.6%25.9%200.00131199.2000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $47.7k $95.3k $143k $190.7k $238.3k APY $184.2k $368.3k $552.5k $736.7k $920.8k $0 $0

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.